Allogene Therapeutics
ALLO
#7115
Rank
NZ$0.75 B
Marketcap
$3.60
Share price
-2.92%
Change (1 day)
-30.30%
Change (1 year)

Revenue for Allogene Therapeutics (ALLO)

Revenue in 2024 (TTM): -NZ$0.04 Million

According to Allogene Therapeutics 's latest financial reports the company's current revenue (TTM ) is -NZ$0.04 Million. In 2023 the company made a revenue of NZ$0.04 Million a decrease over the revenue in the year 2022 that were of NZ$0.38 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allogene Therapeutics from 2018 to 2024

20192020202120222023$10M$20M$30M$40M$50M$60M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) -NZ$0.04 Million-168.95%
2023 NZ$0.04 M-87.61%
2022 NZ$0.38 M-99.32%
2021 NZ$56.34 M
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA